Pages
Self-management facilitator service
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/self-management-facilitator-service
Tissue Viability Update
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/tissue-viability-update
Metal shell of new NHS facility in Chesterfield takes shape ahead of installation
https://dchs.nhs.uk/news/metal-shell-new-nhs-facility-chesterfield-takes-shape-ahead-installation
Records management
Clinical, staff and corporate records management at Derbyshire Community Health Services NHS FT
https://dchs.nhs.uk/about-us/information-governance/records-management
Ashbourne poet’s thanks in verse for NHS nurses is unveiled at St Oswald’s Hospital
https://dchs.nhs.uk/news/ashbourne-poets-thanks-verse-nhs-nurses-unveiled-st-oswalds-hospital
Files
Disclosure Ref 2024245 - Collabrative working with pharmaceutical companies.pdf
Freedom of information disclosure relating to collaborative working with pharmaceutical companies
Tier 3 Specialist Weight Management Service Operational SOP (S157)
The guidance defines what the patient journey through the Tier 3 Specialist Weight Management Service should look like, including: • How referrals are received • How referrals out of the service are completed (to Tier 2 and Tier 4 services) • Clinical thresholds and triage criteria • Patient flow and program content • Prescribing initiation and transition points • MDT roles and responsibilities • Discharge process It also aims to ensure equitable access, clinical safety and consistency in triage and discharge decisions across localities.
Disclosure Ref 2025255 - Guidelines and policies relating to translation and Interrupting services.doc
Freedom of information disclosure relating to guidelines and policies relating to translation and Interrupting services
Disclosure Ref 2025296 - Permanent medical (e.g., Consultant or Specialty Doctor level) Recruitment Data.doc
Freedom of information disclosure relating to details of unfilled permanent medical vacancies, the number of permanent medical appointments made in the past 12 months, and the contact details of the person responsible for permanent medical recruitment.
Disclosure Ref 2025325 - Myeloma patients & specific drugs used.doc
Freedom of information disclosure relating to myeloma patients and the use of specific drugs used for treatment
Corporate Framework August 2025
Corporate Framework August 2025
0535 - Anticoagulation Maintenance Referral Form
0535 - Anticoagulation Maintenance Referral Form
0003 - Continuing Health Care Consent and Basic Information Form
0003 - Continuing Health Care Consent and Basic Information Form
0165 - IPC Terminal Cleaning Schedule for Outpatient areas during COVID-19 (P69)
0165 - IPC Terminal Cleaning Schedule for Outpatient areas during COVID-19
1187 - Enhanced Observation Competency Check List
1187 - Enhanced Observation Competency Check List